20th Anniversary Special - Episode #14 Monoclonal Antibodies - Part 2
Howard Levine, PhD
President, BioProcess Technology Consultants
BioPharmNow Interview
Subscribe to the Podcast
Interview: Howard Levine, PhD, the President of BioProcess Technology Consultants, a consulting firm specializing in biopharmaceutical process development, manufacturing, and engineering.
Listen to BioPharm International’s Managing Editor Chitra Sethi interview Howard Levine on the recent advances in monoclonal antibody therapeutic development.
This is part two of a two-part podcast.
In this episode,
Dr. Levine focuses on the latest selection systems and new technologies to improve expression levels, and how to reduce the costs of MAB development and manufacturing.
Click on the RSS Icon to subscribe to all BioPharmNow podcasts with your installed reader.
If you don't have an RSS reader installed yet, here are some options:
BiopharmNow podcasts are developed and produced by BIOPHARMINTERNATIONAL.COM, a division of Advanstar Communications, Inc., which is solely responsible for podcast content.
